LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Supply Agreement to Boost Molecular Diagnostic Testing in Scandinavia

One of Europe’s leading providers of clinical laboratory testing and medical diagnostic imaging services has signed an agreement for the supply of diagnostic products over the next four years for Sweden and Norway with a Finnish molecular diagnostics company specialized in the development of innovative diagnostics solutions for infectious diseases.  More...
14 Sep 2015

Clinical Applications Transforming Flow Cytometry Sector

Clinical applications of flow cytometry instrumentation and reagents are transforming this market with a high-growth path and emerging active partnerships leveraging increased demand to quantify cell markers, according to a new market analysis.  More...
06 Sep 2015

Partners to Develop and Commercialize Noninvasive Tests for Bladder Cancer

An agreement between a major European university medical center and a multinational biotechnology company was designed to promote commercialization and further development of a liquid biopsy test for the diagnosis of bladder cancer.  More...
30 Aug 2015

Distribution Agreement to Improve Automated Hemostasis Diagnostics

A new, exclusive-distributer agreement will lead to creating a unique high-performance hemostatis work cell by connecting a laboratory automation system from Thermo Fisher Scientific with a hemostasis testing LAS from Instrumentation Laboratory.  More...
23 Aug 2015

Innovative Microbial Diagnostics Developer Acquired by Biomedical Giant

A biotech company noted for its development of innovative products in the field of molecular microbiology diagnostics has been acquired by one of the world's largest biomedical corporations.  More...
23 Aug 2015

Alere Strengthens Core Strategy Through Two New Transactions

Alere, a leader in rapid diagnostics, continues to strengthen focus on its core business strategy through an agreement to sell BBI Group and an acquisition of US Diagnostics.   More...
09 Aug 2015

Cancer Genetics Expands Access to Proprietary Diagnostics Through Agreement with Harvard Pilgrim

Under the terms of a new agreement between Cancer Genetics and Harvard Pilgrim Healthcare, a health care network covering over one million people throughout Massachusetts, Connecticut, and Maine, CGI will offer its cancer diagnostic services to individuals covered under Harvard Pilgrim plans.  More...
02 Aug 2015
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Portable Electronic Pipette
Mini 96
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.